CNTB Connect Biopharma Holdings Limited

Fundamentals / CIK 0001835268 / USD

Connect Biopharma Holdings Limited reported $3.67M in revenue and a net loss of $67.94M for the trailing twelve months ended September 30, 2026 (up 4500.0% year over year), with a -1879.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CNTB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$47.02M$23.51M$0-$191.3MFY 2021 Net Income: -$202.3M2021FY 2022 Net Income: -$118.1M2022FY 2023 Revenue: $0FY 2023 Net Income: -$62.11M2023FY 2024 Revenue: $26.03MFY 2024 Net Income: -$15.63M2024FY 2025 Revenue: $64KFY 2025 Net Income: -$55.48M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $64K $26.03M $0 -- --
Research & Development $37.80M $29.26M $53.00M $96.63M $80.50M
Total Operating Expenses $58.14M $48.48M $69.06M -- --
Operating Income -$58.07M -$22.45M -$69.06M -$119.3M -$98.11M
EBITDA -$57.37M -$21.79M -$68.34M -$118.3M -$97.47M
Interest Income -- -- $2.71M $1.54M $97K
Interest Expense -- -- $23K $21K $18K
Income Before Tax -$55.28M -$15.40M -$61.99M -$117.8M -$202.0M
Income Tax Expense $197K $223K $120K $298K $266K
Net Income -$55.48M -$15.63M -$62.11M -$118.1M -$202.3M
Basic EPS -$1.00 -$0.28 -$1.13 -$2.15 -$3.88
Diluted EPS -$1.00 -$0.28 -$1.13 -$2.15 -$3.88
Basic Shares Outstanding 55.7M 55.2M 55.1M 55.0M 52.2M
Diluted Shares Outstanding 55.7M 55.2M 55.1M 55.0M 52.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $736K $2.77M $169K $0 $16K $48K $0 --
Research & Development $12.79M $16.27M $15.03M $11.28M $11.11M $8.77M $6.63M $6.24M
Total Operating Expenses $17.05M $20.37M $19.78M $15.53M $17.69M $13.47M $11.45M $10.32M
Operating Income -$16.31M -$17.60M -$19.61M -$15.53M -$17.68M -$13.42M -$11.45M -$9.62M
EBITDA -$16.15M -$17.44M -$19.44M -$15.35M -$17.50M -$13.25M -$11.27M -$9.46M
Income Before Tax -$16.13M -$17.22M -$19.35M -$15.08M -$17.14M -$12.84M -$10.22M -$8.80M
Income Tax Expense $20K $60K $48K $27K $61K $55K $54K $106K
Net Income -$16.15M -$17.28M -$19.40M -$15.11M -$17.20M -$12.90M -$10.27M -$8.91M
Basic EPS -$0.26 -$0.27 -$0.34 -- -$0.31 -$0.23 -$0.19 --
Diluted EPS -$0.26 -$0.27 -$0.34 -- -$0.31 -$0.23 -$0.19 --
Basic Shares Outstanding 63.0M 62.9M 56.5M -- 55.7M 55.5M 55.4M --
Diluted Shares Outstanding 63.0M 62.9M 56.5M -- 55.7M 55.5M 55.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $38.34M $78.23M $105.7M $79.01M $267.7M
Short-Term Investments $6.00M $15.48M $12.64M -- --
Cash & Short-Term Investments $44.30M $93.70M $118.3M $79.01M $267.7M
Accounts Receivable, Net $13K $789K $0 -- --
Other Current Assets -- $53K $54K -- --
Total Current Assets $50.93M $96.96M $122.6M $155.8M $275.1M
Property, Plant & Equipment, Net $3.81M $4.05M $4.27M $4.98M $9.31M
Intangible Assets $45K $53K $62K -- --
Long-Term Investments -- -- $0 $0 $0
Other Non-Current Assets $646K $33K $24K $252K $2.95M
Total Non-Current Assets $5.15M $4.32M $4.92M $18.23M $15.93M
Total Assets $56.08M $101.3M $127.4M $174.0M $291.1M
Accounts Payable $1.96M $342K $2.21M -- --
Deferred Revenue (Current) $167K $164K $13.32M $0 $0
Total Current Liabilities $13.61M $8.46M $25.29M $15.62M $17.98M
Deferred Revenue (Non-Current) -- $632K $405K -- --
Other Non-Current Liabilities $114K $632K -- -- --
Total Non-Current Liabilities $482K $656K $585K $897K $810K
Total Liabilities $14.10M $9.12M $25.88M $16.52M $18.80M
Total Debt (incl. Leases) $690K $178K $465K $431K $125K
Common Stock $10K $10K $10K $10K $10K
Retained Earnings -$400.8M -$345.4M -$329.7M -$479.8M -$361.8M
Accumulated Other Comp. Income -$1.19M -$1.67M -$1.01M -$7.63M -$4.03M
Total Stockholders' Equity $41.98M $92.17M $101.5M $158.4M $272.3M
Total Equity $41.98M $92.17M $101.5M $158.4M $272.3M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $16.50M $27.02M $46.03M $38.34M $37.84M $40.63M $47.71M $78.23M
Short-Term Investments $2.99M $4.47M $0 $6.00M $16.94M $31.14M $36.29M $15.48M
Cash & Short-Term Investments $19.50M $31.50M $46.03M $44.30M $54.80M $71.80M $84.00M $93.70M
Accounts Receivable, Net $788K $2.94M $0 $13K $17K $0 $8.0K $789K
Other Current Assets -- -- -- -- -- $228K $65K $53K
Total Current Assets $23.14M $38.62M $55.02M $50.93M $62.60M $77.76M $87.75M $96.96M
Property, Plant & Equipment, Net $3.48M $3.60M $3.70M $3.81M $3.94M $4.05M $3.91M $4.05M
Intangible Assets $40K $42K $43K $45K $47K $48K $50K $53K
Other Non-Current Assets $646K $646K $646K $646K $45K $45K $45K $33K
Total Non-Current Assets $4.63M $4.85M $5.05M $5.15M $4.76M $4.97M $4.93M $4.32M
Total Assets $27.77M $43.47M $60.07M $56.08M $67.36M $82.72M $92.69M $101.3M
Accounts Payable $1.96M $2.02M $4.31M $1.96M $1.99M $2.29M $817K $342K
Deferred Revenue (Current) $0 $0 $0 $167K $165K $164K $164K $164K
Total Current Liabilities $15.49M $16.30M $17.05M $13.61M $11.43M $10.74M $8.56M $8.46M
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- $632K
Other Non-Current Liabilities $103K $107K $111K $114K $118K $122K $627K $632K
Total Non-Current Liabilities $220K $310K $398K $482K $563K $642K $1.22M $656K
Total Liabilities $15.71M $16.61M $17.44M $14.10M $11.99M $11.38M $9.79M $9.12M
Total Debt (incl. Leases) $496K $596K $693K $690K $781K $870K $940K $178K
Common Stock $11K $11K $11K $10K $10K $10K $10K $10K
Retained Earnings -$453.7M -$437.5M -$420.2M -$400.8M -$385.7M -$368.5M -$355.6M -$345.4M
Accumulated Other Comp. Income -$875K -$962K -$1.06M -$1.19M -$1.28M -$1.38M -$1.60M -$1.67M
Total Stockholders' Equity $12.05M $26.86M $42.62M $41.98M $55.37M $71.34M $82.90M $92.17M
Total Equity $12.05M $26.86M $42.62M $41.98M $55.37M $71.34M $82.90M $92.17M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$55.48M -$15.63M -$62.11M -$118.1M -$202.3M
Depreciation & Amortization $704K $660K $720K $1.03M $634K
Stock-Based Compensation $3.73M $6.73M $5.40M $6.91M $8.99M
Change in Receivables $776K -$789K $0 -- --
Change in Payables $1.62M -$1.87M -$1.14M -$776K $8.97M
Operating Cash Flow -$51.21M -$23.61M -$47.74M -$101.5M -$84.32M
Capital Expenditure -$434K -$750K -$81K -$4.41M -$3.83M
Free Cash Flow -$51.64M -$24.36M -$47.82M -$105.9M -$88.16M
Purchases of Investments -$30.47M -$15.45M -$31.03M -- --
Investing Cash Flow $9.82M -$3.45M $74.98M -$86.24M -$5.21M
Share Repurchases -- -- $0 $0 -$566K
Financing Cash Flow $1.09M $227K $45K -$85K $202.2M
Net Change in Cash -$39.89M -$27.43M $26.72M -$187.8M $112.7M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$16.15M -$17.28M -$19.40M -$15.11M -$17.20M -$12.90M -$10.27M -$8.91M
Depreciation & Amortization $162K $161K $164K $181K $179K $171K $173K $158K
Stock-Based Compensation $1.26M $1.26M $1.20M $917K $916K $951K $942K $1.40M
Change in Receivables $2.15M -$2.94M $13K $4.0K -$17K $8.0K $781K $4.23M
Change in Payables -$55K -$2.29M $2.34M -$30K -$300K $1.48M $475K -$41K
Operating Cash Flow -$12.05M -$15.92M -$16.00M -$11.25M -$17.41M -$12.59M -$9.96M -$2.32M
Capital Expenditure -$6.0K $0 $0 -$16K -$34K -$303K -$81K -$313K
Free Cash Flow -$12.06M -$15.92M -$16.00M -$11.27M -$17.44M -$12.89M -$10.04M -$2.63M
Purchases of Investments $0 -$4.47M $0 $0 $0 -$7.91M -$22.56M -$15.45M
Investing Cash Flow $1.49M -$4.47M $6.00M $10.98M $14.35M $5.13M -$20.64M -$15.76M
Common Stock Issued $0 $0 $137K -- $215K $18K $2.0K --
Financing Cash Flow $0 $1.33M $17.62M $715K $215K $161K $2.0K $106K
Net Change in Cash -$10.51M -$19.02M $7.69M $500K -$2.79M -$7.08M -$30.52M -$18.96M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -90740.6% -86.2% -- -- --
Net Profit Margin -86687.5% -60.0% -- -- --
Return on Equity (ROE) -132.2% -17.0% -61.2% -74.5% -74.3%
Return on Assets (ROA) -98.9% -15.4% -48.8% -67.9% -69.5%
Current Ratio 3.74x 11.46x 4.85x 9.97x 15.30x
Quick Ratio 3.26x 11.17x 4.68x 5.06x 14.89x
Debt to Equity 0.02x 0.00x 0.00x 0.00x 0.00x
Revenue Growth (YoY) -99.8% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -1879.9% -2384.5% -28426.6% -90740.6% -- -- -- --
Net Profit Margin -1849.7% -2336.3% -27727.9% -86687.5% -- -- -- --
Return on Equity (ROE) -563.6% -256.8% -151.6% -132.2% -89.0% -63.0% -20.8% -17.0%
Return on Assets (ROA) -244.7% -158.7% -107.6% -98.9% -73.2% -54.3% -18.6% -15.4%
Current Ratio 1.49x 2.37x 3.23x 3.74x 5.48x 7.24x 10.25x 11.46x
Quick Ratio 1.31x 2.11x 2.70x 3.26x 4.80x 6.68x 9.81x 11.17x
Debt to Equity 0.04x 0.02x 0.02x 0.02x 0.01x 0.01x 0.01x 0.00x
Revenue Growth (YoY) +4500.0% +5666.7% -- -- -98.7% -99.8% -- --
Operating Income Growth (YoY) -- -- -- -- -- -198.4% -- --
Net Income Growth (YoY) -- -- -- -- -- -186.9% -- --
EPS Growth (YoY) -- -- -- -- -- -185.2% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001835268) · from December 31, 2021 Data through September 30, 2026 · synced Nov 21, 2026, 05:00 UTC · Open in terminal